Showing results (581-590 of 4,206) with videos related to
Sort By:
Pageof 421
Discover Oncology|December 20, 2024
ALKBH1: emerging biomarker and therapeutic target for cancer treatmentMing Zhu Xiao, Jin Yin Fu, Le Tao Bo, et al.Discover Oncology|December 20, 2024
Converging frontiers in cancer treatment: the role of nanomaterials, mesenchymal stem cells, and microbial agents-challenges and limitationsHamed Afkhami, Aref Yarahmadi, Shoroq Bostani, et al.Discover Oncology|February 10, 2025
LncRNA MSTO2P affects the proliferation, invasion and migration of non-small cell lung cancer by regulating the Wnt/β-catenin pathwayYunfeng Chen, Hai Shi, Yuan Dong, et al.Discover Oncology|February 11, 2025
A novel defined risk signature of ferroptosis-related lncRNAs for predicting prognosis, immune infiltration, and chemotherapy response in multiple myelomaWei Yu, Zizi Jing, Jialin Tang, et al.Discover Oncology|February 11, 2025
MiRNA-21 promotes the migration and proliferation of prostate cancer cells via activating the JAK/STAT pathwayXin Han, Chenjun LvDiscover Oncology|February 8, 2025
Harnessing artificial intelligence for predicting breast cancer recurrence: a systematic review of clinical and imaging dataJaqueline Alvarenga Silveira, Alexandre Ray da Silva, Mariana Zuliani Theodoro de LimaDiscover Oncology|February 7, 2025
Prediction of biochemical prostate cancer recurrence from any Gleason score using robust tissue structure and clinically available informationLaura E Marin, Daniel I Zavaleta-Guzman, Jessyca I Gutierrez-Garcia, et al.Discover Oncology|February 3, 2025
Development of a prognostic model based on four genes related to exhausted CD8+ T cell in triple-negative breast cancer patients: a comprehensive analysis integrating scRNA-seq and bulk RNA-seqYulin Shi, Yang Yu, Jiahan Zhao, et al.Discover Oncology|February 5, 2025
Circadian rhythm related genes signature in glioma for drug resistance prediction: a comprehensive analysis integrating transcriptomics and machine learningJunbo Liao, Yingxing Duan, Xiangwang Xu, et al.Discover Oncology|February 5, 2025
Cancer-associated fibroblast-derived COL17A1 promotes gemcitabine resistance and tumorigenesis in pancreatic cancer cells by interacting with ACTN4Rongyu Shi, Ning Zhang, Han Li, et al.Pageof 421